AP387A - Therapeutical uses of L-methionine and compositions thereof. - Google Patents

Therapeutical uses of L-methionine and compositions thereof. Download PDF

Info

Publication number
AP387A
AP387A APAP/P/1992/000426A AP9200426A AP387A AP 387 A AP387 A AP 387A AP 9200426 A AP9200426 A AP 9200426A AP 387 A AP387 A AP 387A
Authority
AP
ARIPO
Prior art keywords
composition
substance
methionine
conditions
vitamin
Prior art date
Application number
APAP/P/1992/000426A
Other languages
English (en)
Other versions
AP9200426A0 (en
Inventor
Siegbert Heinrich Bissbort
Henry John Davis
Original Assignee
Siegbert Heinrich Bissbort
Henry John Davis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegbert Heinrich Bissbort, Henry John Davis filed Critical Siegbert Heinrich Bissbort
Publication of AP9200426A0 publication Critical patent/AP9200426A0/xx
Application granted granted Critical
Publication of AP387A publication Critical patent/AP387A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/1992/000426A 1991-09-13 1992-09-11 Therapeutical uses of L-methionine and compositions thereof. AP387A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA917334 1991-09-13
ZA917333 1991-09-13
ZA923667 1992-05-20

Publications (2)

Publication Number Publication Date
AP9200426A0 AP9200426A0 (en) 1992-10-31
AP387A true AP387A (en) 1995-07-31

Family

ID=27420971

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000426A AP387A (en) 1991-09-13 1992-09-11 Therapeutical uses of L-methionine and compositions thereof.

Country Status (8)

Country Link
US (1) US5545670A (fr)
EP (1) EP0532369B1 (fr)
AP (1) AP387A (fr)
AT (1) ATE244005T1 (fr)
AU (1) AU666490B2 (fr)
CA (1) CA2078019C (fr)
DE (1) DE69233115T2 (fr)
IL (1) IL103152A (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19504936C1 (de) * 1995-02-15 1996-05-15 Woerwag Pharma Gmbh Arzneimittel auf der Grundlage von Magnesiumchlorid
DE19521314A1 (de) * 1995-06-12 1996-12-19 Max Planck Gesellschaft Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid
US6265391B1 (en) 1995-10-17 2001-07-24 Upsher-Smith Laboratories, Inc. Method for preventing peripheral nerve damage
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6008221A (en) * 1996-11-06 1999-12-28 Bristol-Myers Squibb Company Method for treating Alzheimer's disease with folic acid
SE9604844D0 (sv) * 1996-12-30 1996-12-30 Carl Gerhard Gottfries Medel för terapeutisk behandling av fibromyalgi och kroniskt trötthetssyndrom
US6537997B1 (en) 1997-02-18 2003-03-25 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US6399622B1 (en) 1997-02-18 2002-06-04 A. Martin Lerner Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5872123A (en) 1997-02-18 1999-02-16 Lerner; A. Martin Method for diagnosing and alleviating the symptoms of chronic fatigue syndrome
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
US5770217A (en) * 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
EP0891719A1 (fr) 1997-07-14 1999-01-20 N.V. Nutricia Composition dietique contenant de la methionine
AU741782B2 (en) * 1997-08-21 2001-12-06 P.N. Gerolymatos S.A. Use of phanquinone for the treatment of Alzheimer's disease
US5993866A (en) * 1997-09-12 1999-11-30 Shapira; Niva Process of making food products having reduced methionine ratios
AU746072B2 (en) * 1998-01-13 2002-04-11 Rexall Sundown, Inc. St. John's wort and methyl donor composition and uses thereof
DE69904257T2 (de) * 1999-01-20 2003-04-17 N.V. Nutricia, Zoetermeer Säuglingsnährpräparat
US6274170B1 (en) 1999-02-18 2001-08-14 Richard Heibel Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
GB9906740D0 (en) * 1999-03-23 1999-05-19 Kilgowan Limited Oral combinations of hydroxocobalamin and folic acid
US8642581B1 (en) 2000-02-11 2014-02-04 Brian D. Halevie-Goldman Compositions and methods for the production of S-adenosylmethionine within the body
US7176492B2 (en) * 2001-10-09 2007-02-13 3M Innovative Properties Company Method for forming ceramic microstructures on a substrate using a mold and articles formed by the method
US7033534B2 (en) * 2001-10-09 2006-04-25 3M Innovative Properties Company Method for forming microstructures on a substrate using a mold
US6585998B2 (en) 2001-11-13 2003-07-01 Rudolph Cartwright Nutraceutical composition
AU2003223192A1 (en) * 2002-02-19 2003-09-09 The Regents Of The University Of California Proteins for helicobacter diagnosis
EP1513419A2 (fr) * 2002-06-19 2005-03-16 N.V. Nutricia Procede et composition permettant de traiter ou de prevenir un catabolisme ou de stimuler un anabolisme chez un mammifere soumis au stress metabolique
EP1536781B1 (fr) * 2002-06-19 2010-02-17 N.V. Nutricia Compositions nutritionnelles ou pharmaceutiques pour augmenter la reponse creatinique d'organismes
US20040062821A1 (en) * 2002-10-01 2004-04-01 Elena Avram Administration of therapeutic compositions for treating fatigue
ITTO20040329A1 (it) * 2004-05-18 2004-08-18 Franco Deraco Uso di una composizione farmaceutica per il trattamento di patologie derivate da infezione da herpes virus, papilloma virus,hepatitis virus, nevralgie di origine virale, displasie di origine virale, displasie di origine virale, forme virali per immun
WO2009094006A2 (fr) 2007-10-25 2009-07-30 Wake Forest University Health Sciences Antigènes de protéine de membrane externe de bordetella et leurs procédés de fabrication et d'utilisation
US20140100238A1 (en) 2012-10-04 2014-04-10 Ohio State University Method of diagnosing and treating epstein barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
FR3024019B1 (fr) * 2014-07-28 2017-11-24 Yvan Erbs Complement alimentaire pour ameliorer le fonctionnement des cellules vivantes et procede associe

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088016A1 (fr) * 1982-03-01 1983-09-07 Pharmuka Laboratoires Médicament à base de L-méthionine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2126134A1 (en) * 1971-02-26 1972-10-06 Ates Ibrahim Cyclophosphamide/magnesium compsns - with enhanced cytostatic activity
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
CH603069A5 (fr) * 1974-11-21 1978-08-15 Interchemie Ag
DE2915433A1 (de) * 1979-04-17 1980-10-30 Christensen Plantorgan Werk Verwendung von physiologisch vertraeglichen methyldonatoren
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4885157A (en) * 1987-02-13 1989-12-05 Fiaschetti Mary G Dermal cosmetic composition and applications therefor
DE3707127C2 (de) * 1987-03-05 1996-06-20 Zambon Spa Verwendung von Methionin zur Behandlung von Immun-Schwächeerkrankungen bei Virusinfektionen und/oder bei Tumorerkrankungen
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
US4927850A (en) * 1988-04-08 1990-05-22 Bayless Robert K Antioxidant compositions and methods for ameliorating inflammatory symptoms of respiratory disease
US5055296A (en) * 1988-08-04 1991-10-08 Wagle Sudhakar S Method of treating chronic fatigue syndrome
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088016A1 (fr) * 1982-03-01 1983-09-07 Pharmuka Laboratoires Médicament à base de L-méthionine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C.A. Vol. 96 (1982) 96:1555200w *
Merck Ondex (1989) P 5906-5896 *
Rote List 1986, 81,086 *

Also Published As

Publication number Publication date
EP0532369A2 (fr) 1993-03-17
AU2352792A (en) 1993-03-18
ATE244005T1 (de) 2003-07-15
CA2078019C (fr) 2002-08-27
IL103152A (en) 1998-08-16
AP9200426A0 (en) 1992-10-31
US5545670A (en) 1996-08-13
DE69233115T2 (de) 2004-05-06
CA2078019A1 (fr) 1993-03-14
AU666490B2 (en) 1996-02-15
EP0532369B1 (fr) 2003-07-02
EP0532369A3 (fr) 1994-01-19
DE69233115D1 (de) 2003-08-07
IL103152A0 (en) 1993-02-21

Similar Documents

Publication Publication Date Title
AP387A (en) Therapeutical uses of L-methionine and compositions thereof.
EP1390049B1 (fr) Preparations de traitement de maladies et de syndromes animaux comprenant du facteur de transfer
AU2002311871A1 (en) Compositions for treating animal diseases and syndromes
Hertz The quantitative relationship between stilbestrol response and dietary “folic acid” in the chick
TWI407963B (zh) Contains the composition of riboflavin and sesamin
KR20070054739A (ko) 종합 경장 영양 조성물
CN105832759B (zh) 一种预防和/或治疗由冠状病毒属和/或轮状病毒属病毒引发的疾病的药物组合物
Oyawoye et al. Potential of chemical regulation of food intake and body weight of broiler breeder chicks
Cowgill et al. Studies in the Physiology of Vitamins: III. Quantitative Aspects of the Relation Between Vitamin B and Appetite in the Dog
EP1183037B1 (fr) Compositions pour la modulation de la reponse immunitaire et le traitement des maladies inflammatoires
Gossellin et al. Evaluation of dirlotapide for sustained weight loss in overweight Labrador retrievers
WO2016112552A1 (fr) Utilisation de taurine pour la prévention et/ou le traitement de maladies virales à coronavirus et/ou rotavirus
Silber Studies of Pantothenic Acid Deficiency in Dogs: Three Figures
Bird et al. Generalized Edema in Chicks Prevented by d, 1-Alpha Tocopherol.
Abd-Allah et al. Influence of using flavomycin and propolis as feed additives on buffalo milk production, and growth performance and blood metabolites of suckling calves
RU2425674C2 (ru) Комплексный фармацевтический препарат
US11766458B2 (en) Method and a dietary composition on regulation, treatment, and prevention of obesity
RU2308188C2 (ru) Применение корма, обработанного полиферментным препаратом "гимизим", при отравлении животных и кур тяжелыми металлами
RU2195838C2 (ru) Препарат для стимуляции роста и повышения резистентности сельскохозяйственных, домашних животных и птицы
US5215977A (en) Method for treating leg weakness in fowl
RU2599499C1 (ru) Способ лечения гепатоза молочных коров в условиях техногенных провинций с избытком свинца, никеля и кадмия
AU2008200364A1 (en) Compositions for treating animal diseases and syndromes
CN105832714B (zh) 牛磺酸在预防和/或治疗由冠状病毒属和/或轮状病毒属病毒引发的疾病中的应用
JPH0531527B2 (fr)
RU2227026C1 (ru) Способ профилактики и лечения гепатодистрофии поросят